Patents by Inventor Aparna Sundaram

Aparna Sundaram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11643388
    Abstract: Disclosed herein, inter alia, are inhibitors of alpha 2 beta 1 integrin and methods of using the same.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: May 9, 2023
    Assignees: The Regents of the University of California, ShangPharma Innovation Inc.
    Inventors: Dean Sheppard, William F. DeGrado, Aparna Sundaram, Hyunil Jo, Richard Beresis, Marc Adler
  • Patent number: 11597727
    Abstract: Disclosed herein, inter alia, are inhibitors of integrin alpha 2 beta 1 and methods of using the same.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: March 7, 2023
    Assignee: The Regents of the University of California
    Inventors: Dean Sheppard, Aparna Sundaram, William F. DeGrado, Hyunil Jo
  • Publication number: 20220411366
    Abstract: Disclosed herein, inter alia, are inhibitors of alpha 2 beta 1 integrin and methods of using the same.
    Type: Application
    Filed: April 30, 2021
    Publication date: December 29, 2022
    Inventors: Dean Sheppard, William F. DeGrado, Aparna Sundaram, Hyunil Jo, Richard Beresis, Marc Adler
  • Patent number: 11530180
    Abstract: The disclosure provides, inter alia, alpha-5 beta-1 inhibitors, pharmaceutical compositions comprising alpha-5 beta-1 inhibitors, methods for treating diseases using alpha-5 beta-1 inhibitors, and processes for making alpha-5 beta-1 inhibitors.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: December 20, 2022
    Assignees: The Regents of the University of California, Shanghai ChemPartner Co., Ltd.
    Inventors: Dean Sheppard, William F. DeGrado, Hyunil Jo, Aparna Sundaram, Richard Beresis
  • Publication number: 20210387986
    Abstract: Disclosed herein, inter alia, are inhibitors of integrin alpha 2 beta 1 and methods of using the same.
    Type: Application
    Filed: March 13, 2019
    Publication date: December 16, 2021
    Inventors: Dean Sheppard, Aparna Sundaram, William F. DeGrado, Hyunil Jo
  • Publication number: 20210171455
    Abstract: The disclosure provides, inter alia, alpha-5 beta-1 inhibitors, pharmaceutical compositions comprising alpha-5 beta-1 inhibitors, methods for treating diseases using alpha-5 beta-1 inhibitors, and processes for making alpha-5 beta-1 inhibitors.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 10, 2021
    Inventors: Dean Sheppard, William F. DeGrado, Hyunil Jo, Aparna Sundaram, Richard Beresis
  • Patent number: 10836720
    Abstract: Disclosed herein, inter alia, are inhibitors of integrin alpha 5 beta 1 and methods of using the same.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: November 17, 2020
    Assignee: The Regents of the University of California
    Inventors: Dean Sheppard, Aparna Sundaram, William F. Degrado, Hyunil Jo, Joel McIntosh
  • Publication number: 20190144386
    Abstract: Disclosed herein, inter alia, are inhibitors of integrin alpha 5 beta 1 and methods of using the same.
    Type: Application
    Filed: March 31, 2017
    Publication date: May 16, 2019
    Inventors: Dean Sheppard, Aparna Sundaram, William F. Degrado, Hyunil Jo, Joel McIntosh